Funder: National Institutes of Health

Due Dates: February 5, 2025 (New) | March 5, 2025 (Renewal/Resubmission/Revision) | June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | Expires January 8, 2026

Funding Amounts: No budget cap; budgets must reflect actual project needs. Project period up to 5 years.

Summary: Supports mechanistic and epidemiologic research on the roles of co-infection (excluding HIV) in cancer causation, prevention, and treatment, with emphasis on novel opportunities and understudied populations.

Key Information: Clinical trials are not allowed; applications focused solely on HIV co-infection or a single pathogen are not responsive.